Biotech

General Motors and Honda reach milestone in hydrogen fuel cell joint venture Production starts at factory in southeast Michigan Main ideas: General Motors and Honda have announced that their hydrogen fuel cell joint venture has achieved a significant milestone with the beginning of production at a factory located in southeast Michigan. Author's take: This news marks a milestone achievement for General Motors and Honda in their joint venture focused on hydrogen fuel cell technology. The start of production at the new factory in Michigan is a positive step towards the commercialization of this innovative and sustainable energy source. It will be interesting to see how this partnership develops and whether it leads to wider adoption of hydrogen fuel cell vehicles in the future. Click here ...

Machine Learning Tool, A-Plus, Makes the Grade for Liquid Biopsies: Study Main Ideas: A machine-learning algorithm called A-PLUS has been developed and tested by researchers for early detection of cancer through blood-based liquid biopsies. The algorithm analyzes the representation of Alu elements in plasma cell-free DNA to distinguish cancer patients from those without cancer. A-PLUS was validated and tested across four cohorts of patients, including thousands of samples from different types of solid tumors. This technology could potentially enable easier and less invasive detection of cancer through smaller blood draws. Author's Take: Researchers have successfully developed and tested a machine-learning algorithm, A-PLUS, which may revolutionize cancer detection through...

Improving Flow through the Cell Therapies Bottleneck Main Ideas: CRISPR is a foundational technology used in cell-based therapies for various diseases. There are still questions about reimbursement, durability, preconditioning regimens, off-target effects, and long-term safety of genome editing therapies. Despite these concerns, it is evident that CRISPR-related technologies will continue to revolutionize the treatment of previously untreatable diseases. Author's Take: CRISPR has become a game-changer in the field of cell-based therapies, providing hope for patients with intractable diseases. However, challenges such as reimbursement, safety, and durability must be addressed to fully utilize the potential of CRISPR-related technologies. Nonetheless, the future looks promising as CRISPR c...